Terminated NA INTERVENTIONAL 1-arm NCT03721042

Demonstrating the Diagnostic Power of an Electronic Nose: Study on Exhaled Air Samples (OLFADIAG)

Demonstrating the Diagnostic Power of an Electronic Nose: Pilot Study on Exhaled Air Samples

Sponsor: Nouvelle Clinique Bonnefon

Conditions Alzheimer Disease Gastric Cancer Pneumological Cancer Urologic Cancer

Interventions olfactory measuring device

Updated 7 times since 2018 Last updated: Apr 7, 2022 Started: Oct 11, 2018 Primary completion: Nov 5, 2019 Completion: Oct 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

no PI to continue the study

Other Alzheimer Disease trials with similar outcome

Browse all Alzheimer Disease trials

A NA clinical study on Alzheimer Disease and Gastric Cancer, this trial is terminated or withdrawn. The trial is conducted by Nouvelle Clinique Bonnefon and has accumulated 7 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated NA
Sep 2024 — Sep 2025 [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
May 2022 — Jul 2024 [monthly]

Terminated NA

Status: Unknown Status → Terminated
Jan 2021 — May 2022 [monthly]

Unknown Status NA

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Nov 2018 — Nov 2020 [monthly]

Not Yet Recruiting NA

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nouvelle Clinique Bonnefon
University Hospital, Montpellier

Data source: Nouvelle Clinique Bonnefon

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Alès, France